Q32 Bio Inc (NASDAQ:QTTB) price on Thursday, July 03, remained unchanged to $1.44.
A look at the stock’s price movement, the close in the last trading session was $1.44, moving within a range at $1.4 and $1.4617. Turning to its 52-week performance, $53.79 and $1.38 were the 52-week high and 52-week low respectively. Overall, QTTB moved -25.00% over the past month.
Q32 Bio Inc’s market cap currently stands at around $17.56 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that QTTB is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend QTTB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
QTTB’s current price about -10.68% and -13.75% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 36.01, while 7-day volatility ratio is 7.35% and 7.34% in the 30-day chart. Further, Q32 Bio Inc (QTTB) has a beta value of -0.03. Analysts have given the company’s stock an average 52-week price target of $59, forecast between a low of $45 and high of $95. Looking at the price targets, the low is -3025.0% off current price level while to achieve the yearly target high, price needs to move -6497.22%. Nonetheless, investors will most likely welcome a -3997.22% jump to $59 which is the analysts’ median price.
If we refocus on Q32 Bio Inc (NASDAQ:QTTB), historical trading data shows that trading volumes averaged 0.15 over the past 10 days and 159.96K over the past 3 months. The company’s latest data on shares outstanding shows there are 12.20 million shares.
The 63.56% of Q32 Bio Inc’s shares are in the hands of company insiders while institutional holders own 18.97% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.38 million on 2025-06-13, giving us a short ratio of 3.45. The data shows that as of 2025-06-13 short interest in Q32 Bio Inc (QTTB) stood at 1121.0 of shares outstanding, with shares short falling to 0.63 million registered in 2025-05-15. Current price change has pushed the stock -92.41% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the QTTB stock continues to rise going into the next quarter.
